Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Interventions for morphea.

Albuquerque JV, Andriolo BN, Vasconcellos MR, Civile VT, Lyddiatt A, Trevisani VF.

Cochrane Database Syst Rev. 2019 Jul 16;7:CD005027. doi: 10.1002/14651858.CD005027.pub5. Review.

PMID:
31309547
2.

PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis.

Bingham Iii CO, Gutierrez AK, Butanis A, Bykerk VP, Curtis JR, Leong A, Lyddiatt A, Nowell WB, Orbai AM, Bartlett SJ.

J Patient Rep Outcomes. 2019 Feb 21;3(1):14. doi: 10.1186/s41687-019-0105-6.

3.

Patient Perspectives on DMARD Safety Concerns in Rheumatology Trials: Results from Inflammatory Arthritis Patient Focus Groups and OMERACT Attendees Discussion.

Andersen KM, Kelly A, Lyddiatt A, Bingham CO 3rd, Bykerk VP, Batterman A, Westreich J, Jones MK, Cross M, Brooks PM, March L, Shea B, Tugwell P, Simon LS, Christensen R, Bartlett SJ.

J Rheumatol. 2019 Feb 15. pii: jrheum.181185. doi: 10.3899/jrheum.181185. [Epub ahead of print]

PMID:
30770516
4.

OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions.

Toupin-April K, Barton JL, Fraenkel L, Meara A, Li LC, Brooks P, de Wit M, Stacey D, Légaré F, Shea B, Lyddiatt A, Hofstetter C, Christensen R, Scholte Voshaar M, Suarez-Almazor ME, Boonen A, Meade T, March L, Jull JE, Campbell W, Alten R, Karuranga S, Morgan EM, Kelly A, Kaufman J, Hill S, Maxwell LJ, Beaton D, El-Miedany Y, Mittoo S, Bartlett SJ, Singh JA, Tugwell PS.

J Rheumatol. 2019 Feb 1. pii: jrheum.181071. doi: 10.3899/jrheum.181071. [Epub ahead of print]

PMID:
30709963
5.

Is quality of life a suitable measure of patient decision aid effectiveness? Sub-analysis of a Cochrane systematic review.

Rutherford C, King MT, Butow P, Legare F, Lyddiatt A, Souli I, Rincones O, Stacey D.

Qual Life Res. 2019 Mar;28(3):593-607. doi: 10.1007/s11136-018-2045-7. Epub 2018 Nov 13. Review.

PMID:
30426276
6.

Added value of combining methotrexate with a biological agent compared to biological monotherapy in rheumatoid arthritis patients: A systematic review and meta-analysis of randomised trials.

Tarp S, Jørgensen TS, Furst DE, Dossing A, Taylor PC, Choy EH, Suarez-Almazor ME, Lyddiatt A, Kristensen LE, Bliddal H, Christensen R.

Semin Arthritis Rheum. 2019 Jun;48(6):958-966. doi: 10.1016/j.semarthrit.2018.10.002. Epub 2018 Oct 9.

PMID:
30396592
7.

Interventions for increasing the use of shared decision making by healthcare professionals.

Légaré F, Adekpedjou R, Stacey D, Turcotte S, Kryworuchko J, Graham ID, Lyddiatt A, Politi MC, Thomson R, Elwyn G, Donner-Banzhoff N.

Cochrane Database Syst Rev. 2018 Jul 19;7:CD006732. doi: 10.1002/14651858.CD006732.pub4. Review.

8.

Combining online and in-person methods to evaluate the content validity of PROMIS fatigue short forms in rheumatoid arthritis.

Bartlett SJ, Gutierrez AK, Butanis A, Bykerk VP, Curtis JR, Ginsberg S, Leong AL, Lyddiatt A, Nowell WB, Orbai AM, Smith KC, Bingham CO 3rd.

Qual Life Res. 2018 Sep;27(9):2443-2451. doi: 10.1007/s11136-018-1880-x. Epub 2018 May 24.

PMID:
29797175
9.

The prevalence of patient engagement in published trials: a systematic review.

Fergusson D, Monfaredi Z, Pussegoda K, Garritty C, Lyddiatt A, Shea B, Duffett L, Ghannad M, Montroy J, Murad MH, Pratt M, Rader T, Shorr R, Yazdi F.

Res Involv Engagem. 2018 May 22;4:17. doi: 10.1186/s40900-018-0099-x. eCollection 2018.

10.

Development of a Canadian Core Clinical Dataset to Support High-quality Care for Canadian Patients with Rheumatoid Arthritis.

Barber CEH, Mosher DP, Ahluwalia V, Zummer M, Marshall DA, Choquette D, Lacaille D, Bombardier C, Lyddiatt A, Chandran V, Khodyakov D, Dao E, Barnabe C; RACCD Working Group.

J Rheumatol. 2017 Dec;44(12):1813-1822. doi: 10.3899/jrheum.170421. Epub 2017 Oct 1.

11.

When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework.

Jull J, Whitehead M, Petticrew M, Kristjansson E, Gough D, Petkovic J, Volmink J, Weijer C, Taljaard M, Edwards S, Mbuagbaw L, Cookson R, McGowan J, Lyddiatt A, Boyer Y, Cuervo LG, Armstrong R, White H, Yoganathan M, Pantoja T, Shea B, Pottie K, Norheim O, Baird S, Robberstad B, Sommerfelt H, Asada Y, Wells G, Tugwell P, Welch V.

BMJ Open. 2017 Sep 25;7(9):e015815. doi: 10.1136/bmjopen-2016-015815.

12.

Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report.

Bartlett SJ, Barbic SP, Bykerk VP, Choy EH, Alten R, Christensen R, den Broeder A, Fautrel B, Furst DE, Guillemin F, Hewlett S, Leong AL, Lyddiatt A, March L, Montie P, Pohl C, Scholte Voshaar M, Woodworth TG, Bingham CO 3rd.

J Rheumatol. 2017 Oct;44(10):1536-1543. doi: 10.3899/jrheum.161145. Epub 2017 Aug 15.

13.

Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting.

Toupin-April K, Barton J, Fraenkel L, Li LC, Brooks P, De Wit M, Stacey D, Légaré F, Meara A, Shea B, Lyddiatt A, Hofstetter C, Gossec L, Christensen R, Scholte-Voshaar M, Suarez-Almazor ME, Boonen A, Meade T, March L, Pohl C, Jull JE, Sivarajah S, Campbell W, Alten R, Karuranga S, Morgan E, Kaufman J, Hill S, Maxwell LJ, Welch V, Beaton D, El-Miedany Y, Tugwell PS.

J Rheumatol. 2017 Oct;44(10):1544-1550. doi: 10.3899/jrheum.161241. Epub 2017 Aug 1.

14.

Montreal Accord on Patient-Reported Outcomes (PROs) use series - Paper 3: patient-reported outcomes can facilitate shared decision-making and guide self-management.

Noonan VK, Lyddiatt A, Ware P, Jaglal SB, Riopelle RJ, Bingham CO 3rd, Figueiredo S, Sawatzky R, Santana M, Bartlett SJ, Ahmed S.

J Clin Epidemiol. 2017 Sep;89:125-135. doi: 10.1016/j.jclinepi.2017.04.017. Epub 2017 Apr 20.

PMID:
28433671
15.

Decision aids for people facing health treatment or screening decisions.

Stacey D, Légaré F, Lewis K, Barry MJ, Bennett CL, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Thomson R, Trevena L.

Cochrane Database Syst Rev. 2017 Apr 12;4:CD001431. doi: 10.1002/14651858.CD001431.pub5. Review.

16.

Emerging Guidelines for Patient Engagement in Research.

Kirwan JR, de Wit M, Frank L, Haywood KL, Salek S, Brace-McDonnell S, Lyddiatt A, Barbic SP, Alonso J, Guillemin F, Bartlett SJ.

Value Health. 2017 Mar;20(3):481-486. doi: 10.1016/j.jval.2016.10.003. Epub 2016 Nov 17.

17.

Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.

Petkovic J, Barton JL, Flurey C, Goel N, Bartels CM, Barnabe C, de Wit MPT, Lyddiatt A, Lacaille D, Welch V, Boonen A, Shea B, Christensen R, Maxwell LJ, Campbell W, Jull J, Toupin-April K, Singh JA, Goldsmith CH, Sreih AG, Pohl C, Hofstetter C, Beaton DE, Buchbinder R, Guillemin F, Tugwell PS.

J Rheumatol. 2017 Nov;44(11):1727-1733. doi: 10.3899/jrheum.160975. Epub 2017 Feb 15.

18.

Marine Oil Supplements for Arthritis Pain: A Systematic Review and Meta-Analysis of Randomized Trials.

Senftleber NK, Nielsen SM, Andersen JR, Bliddal H, Tarp S, Lauritzen L, Furst DE, Suarez-Almazor ME, Lyddiatt A, Christensen R.

Nutrients. 2017 Jan 6;9(1). pii: E42. doi: 10.3390/nu9010042. Review.

19.

Stiffness Is the Cardinal Symptom of Inflammatory Musculoskeletal Diseases, Yet Still Variably Measured: Report from the OMERACT 2016 Stiffness Special Interest Group.

Halls S, Sinnathurai P, Hewlett S, Mackie SL, March L, Bartlett SJ, Bingham CO 3rd, Alten R, Campbell I, Hill CL, Holt RJ, Hughes R, Kirwan JR, Leong AL, Leung YY, Lyddiatt A, Neill L, Orbai AM.

J Rheumatol. 2017 Dec;44(12):1904-1910. doi: 10.3899/jrheum.161073. Epub 2016 Dec 15.

20.

Establishing the values for patient engagement (PE) in health-related quality of life (HRQoL) research: an international, multiple-stakeholder perspective.

Haywood K, Lyddiatt A, Brace-McDonnell SJ, Staniszewska S, Salek S.

Qual Life Res. 2017 Jun;26(6):1393-1404. doi: 10.1007/s11136-016-1465-5. Epub 2016 Dec 8.

21.

Successful Stepwise Development of Patient Research Partnership: 14 Years' Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT).

de Wit M, Kirwan JR, Tugwell P, Beaton D, Boers M, Brooks P, Collins S, Conaghan PG, D'Agostino MA, Hofstetter C, Hughes R, Leong A, Lyddiatt A, March L, May J, Montie P, Richards P, Simon LS, Singh JA, Strand V, Voshaar M, Bingham CO 3rd, Gossec L.

Patient. 2017 Apr;10(2):141-152. doi: 10.1007/s40271-016-0198-4.

22.

Development and Alpha-testing of a Stepped Decision Aid for Patients Considering Nonsurgical Options for Knee and Hip Osteoarthritis Management.

Toupin April K, Rader T, Hawker GA, Stacey D, O'Connor AM, Welch V, Lyddiatt A, McGowan J, Thorne JC, Bennett C, Pardo Pardo J, Wells GA, Tugwell P.

J Rheumatol. 2016 Oct;43(10):1891-1896. Epub 2016 Sep 1.

PMID:
27585691
23.

Wait times to rheumatology care for patients with rheumatic diseases: a data linkage study of primary care electronic medical records and administrative data.

Widdifield J, Bernatsky S, Thorne JC, Bombardier C, Jaakkimainen RL, Wing L, Paterson JM, Ivers N, Butt D, Lyddiatt A, Hofstetter C, Ahluwalia V, Tu K.

CMAJ Open. 2016 May 11;4(2):E205-12. doi: 10.9778/cmajo.20150116. eCollection 2016 Apr-Jun.

24.

Translating Evidence to Facilitate Shared Decision Making: Development and Usability of a Consult Decision Aid Prototype.

Stacey D, Légaré F, Lyddiatt A, Giguere AM, Yoganathan M, Saarimaki A, Pardo JP, Rader T, Tugwell P.

Patient. 2016 Dec;9(6):571-582.

25.

Patterns of Care Among Patients Referred to Rheumatologists in Ontario, Canada.

Widdifield J, Tu K, Carter Thorne J, Bombardier C, Michael Paterson J, Liisa Jaakkimainen R, Wing L, Butt DA, Ivers N, Hofstetter C, Lyddiatt A, Ahluwalia V, Bernatsky S.

Arthritis Care Res (Hoboken). 2017 Jan;69(1):104-114. doi: 10.1002/acr.22910. Epub 2016 Nov 16.

26.

Current State of Reporting Pain Outcomes in Cochrane Reviews of Chronic Musculoskeletal Pain Conditions and Considerations for an OMERACT Research Agenda.

Maxwell LJ, Wells GA, Simon LS, Conaghan PG, Grosskleg S, Scrivens K, Beaton DE, Bingham CO 3rd, Busse JW, Christensen R, Goel N, Jüni P, Kaiser U, Lyddiatt A, Mease PJ, Ostelo RW, Phillips K, Sapunar D, Singh JA, Strand V, Taylor AM, Terwee CB, Tugwell P.

J Rheumatol. 2015 Oct;42(10):1934-1942. doi: 10.3899/jrheum.141423. Epub 2015 Sep 15.

27.

Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome Measures.

Petkovic J, Epstein J, Buchbinder R, Welch V, Rader T, Lyddiatt A, Clerehan R, Christensen R, Boonen A, Goel N, Maxwell LJ, Toupin-April K, De Wit M, Barton J, Flurey C, Jull J, Barnabe C, Sreih AG, Campbell W, Pohl C, Duruöz MT, Singh JA, Tugwell PS, Guillemin F.

J Rheumatol. 2015 Dec;42(12):2448-59. doi: 10.3899/jrheum.141168. Epub 2015 Jun 15. Review.

28.

Development of a Draft Core Set of Domains for Measuring Shared Decision Making in Osteoarthritis: An OMERACT Working Group on Shared Decision Making.

Toupin-April K, Barton J, Fraenkel L, Li L, Grandpierre V, Guillemin F, Rader T, Stacey D, Légaré F, Jull J, Petkovic J, Scholte-Voshaar M, Welch V, Lyddiatt A, Hofstetter C, De Wit M, March L, Meade T, Christensen R, Gaujoux-Viala C, Suarez-Almazor ME, Boonen A, Pohl C, Martin R, Tugwell PS.

J Rheumatol. 2015 Dec;42(12):2442-7. doi: 10.3899/jrheum.141205. Epub 2015 Apr 15. Review.

29.

Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary.

Bartlett SJ, Bykerk VP, Cooksey R, Choy EH, Alten R, Christensen R, Furst DE, Guillemin F, Halls S, Hewlett S, Leong AL, Lyddiatt A, March L, Montie P, Orbai AM, Pohl C, Voshaar MS, Woodworth TG, Bingham CO 3rd.

J Rheumatol. 2015 Nov;42(11):2185-9. doi: 10.3899/jrheum.141169. Epub 2015 Feb 15. Review.

30.

Interventions for improving the adoption of shared decision making by healthcare professionals.

Légaré F, Stacey D, Turcotte S, Cossi MJ, Kryworuchko J, Graham ID, Lyddiatt A, Politi MC, Thomson R, Elwyn G, Donner-Banzhoff N.

Cochrane Database Syst Rev. 2014 Sep 15;(9):CD006732. doi: 10.1002/14651858.CD006732.pub3. Review. Update in: Cochrane Database Syst Rev. 2018 Jul 19;7:CD006732.

PMID:
25222632
31.

Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop.

Bykerk VP, Lie E, Bartlett SJ, Alten R, Boonen A, Christensen R, Furst DE, Hewlett S, Leong AL, Lyddiatt A, March L, May JE, Montie P, Orbai AM, Pohl C, Scholte Voshaar M, Woodworth T, Bingham CO 3rd, Choy EH.

J Rheumatol. 2014 Apr;41(4):799-809. doi: 10.3899/jrheum.131252. Epub 2014 Mar 1. Review.

32.

Updating the OMERACT filter: implications for patient-reported outcomes.

Kirwan JR, Bartlett SJ, Beaton DE, Boers M, Bosworth A, Brooks PM, Choy E, de Wit M, Guillemin F, Hewlett S, Kvien TK, Landewé RB, Leong AL, Lyddiatt A, March L, May J, Montie PL, Nikaï E, Richards P, Voshaar MM, Smeets W, Strand V, Tugwell P, Gossec L.

J Rheumatol. 2014 May;41(5):1011-5. doi: 10.3899/jrheum.131312. Epub 2014 Mar 1.

PMID:
24584919
33.

Decision aids for people facing health treatment or screening decisions.

Stacey D, Légaré F, Col NF, Bennett CL, Barry MJ, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Thomson R, Trevena L, Wu JH.

Cochrane Database Syst Rev. 2014 Jan 28;(1):CD001431. doi: 10.1002/14651858.CD001431.pub4. Review. Update in: Cochrane Database Syst Rev. 2017 Apr 12;4:CD001431.

PMID:
24470076
34.

Including health equity considerations in development of instruments for rheumatology research: an introduction to a novel OMERACT paradigm.

O'Neill J, Rader T, Guillemin F, Boonen A, Christensen R, Lyddiatt A, Pardo JP, Welch V, Singh JA, Tugwell P.

J Rheumatol. 2014 Jan;41(1):150-2. doi: 10.3899/jrheum.130812. Epub 2013 Oct 15.

PMID:
24128775
35.

Prevention and self-management interventions are top priorities for osteoarthritis systematic reviews.

Jaramillo A, Welch VA, Ueffing E, Gruen RL, Bragge P, Lyddiatt A, Tugwell P.

J Clin Epidemiol. 2013 May;66(5):503-510.e4. doi: 10.1016/j.jclinepi.2012.06.017. Epub 2012 Sep 18.

PMID:
22995854
36.

Translation and validation of the Dutch version of the Effective Consumer Scale (EC-17).

ten Klooster PM, Taal E, Siemons L, Oostveen JC, Harmsen EJ, Tugwell PS, Rader T, Lyddiatt A, van de Laar MA.

Qual Life Res. 2013 Mar;22(2):423-9. doi: 10.1007/s11136-012-0162-2. Epub 2012 Mar 28.

37.

Decision aids for people facing health treatment or screening decisions.

Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Légaré F, Thomson R.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD001431. doi: 10.1002/14651858.CD001431.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD001431.

PMID:
21975733
38.

Influencing health equity: role of the effective consumer scale in measuring skills and abilities in a middle income country.

Rader T, Ueffing E, Garcia-Elorrio E, Idzerda L, Ciapponi A, Irazola V, Welch V, Lyddiatt A, Shea B, Newman S, Osborne R, Tugwell PS.

J Rheumatol. 2011 Aug;38(8):1798-802. doi: 10.3899/jrheum.110407.

PMID:
21807803
39.

Redefinition of working aqueous two-phase systems: a generic description for prediction of the effective phase chemical composition for process control and biorecovery.

Selvakumar P, Ling TC, Walker S, Lyddiatt A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Jul 1;878(21):1784-90. doi: 10.1016/j.jchromb.2010.05.004. Epub 2010 May 11.

PMID:
20570574
40.

Responsiveness of the Effective Consumer Scale (EC-17).

Santesso N, Rader T, Wells GA, O'Connor AM, Brooks PM, Driedger M, Gallois C, Kristjansson E, Lyddiatt A, O'Leary G, Prince M, Stacey D, Wale J, Welch V, Wilson AJ, Tugwell PS.

J Rheumatol. 2009 Sep;36(9):2087-91. doi: 10.3899/jrheum.090363.

PMID:
19738218
41.

Rapid titration of adenoviral infectivity by flow cytometry in batch culture of infected HEK293 cells.

Gueret V, Negrete-Virgen JA, Lyddiatt A, Al-Rubeai M.

Cytotechnology. 2002 Jan;38(1-3):87-97. doi: 10.1023/A:1021106116887.

42.

Implementing arthritis clinical practice guidelines in primary care.

Lineker SC, Bell MJ, Boyle J, Badley EM, Flakstad L, Fleming J, Lyddiatt A, Macdonald J, McCarthy J, Zummer M.

Med Teach. 2009 Mar;31(3):230-7. doi: 10.1080/01421590802158377.

PMID:
18825571
43.

Aqueous two-phase recovery of bio-nanoparticles: a miniaturization study for the recovery of bacteriophage T4.

Negrete A, Ling TC, Lyddiatt A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jul 1;854(1-2):13-9. Epub 2007 Apr 7.

PMID:
17448735
44.

Preparation and purification of synthetic protein nanoparticulates.

Jahanshahi M, Williams S, Lyddiatt A, Shojaosadati SA.

IEE Proc Nanobiotechnol. 2004 Oct;151(5):176-82.

PMID:
16475865
45.

Subtractive chromatography for purification and recovery of nano-bioproducts.

Jahanshahi M, Zhang Z, Lyddiatt A.

IEE Proc Nanobiotechnol. 2005 Jun;152(3):121-6.

PMID:
16441168
48.

Direct enzyme adsorption from an unclarified microbial feedstock using suspended bed chromatography.

Ling TC, Lyddiatt A, Carmichael I, Purdom G, Hathi P, Levison PR.

J Chromatogr A. 2003 Mar 7;989(1):109-18.

PMID:
12641287
49.
50.

Supplemental Content

Loading ...
Support Center